Frontlight ResearchEarly access
Taking people in United StatesNo phase
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
Key facts
- Who runs it
- Northwell Health
- Where
- Manhasset, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 1 Apr 2021
- Expected to end
- 1 Dec 2027
- Type of study
- Observational
- Treatments tested
- Methylprednisolone
- Record updated
- 26 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 24 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form (in person or via telehealth)
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged >18 years old
- Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol
- Patients presenting with all types of post-concussive headache with >5/10 in severity on the numerical analog scale
- Headache that occurs for > 4 hours per day
- Headache that occurs every day
- Headache that began after concussion, patient was diagnosed at an outpatient clinic or was hospitalized
- Headache developed within 7 days post-injury and patient presenting within 30 days from initial trauma
- A diagnosis of concussion
- If a patient is taking another pain medication, this still be included in the stud
Who cannot take part
- Any contraindication to corticosteroids
- Currently on corticosteroids for another reason
- Any evidence of known intracranial hemorrhage on neuroimaging
- Allergy or sensitivity to corticosteroids
- Active Tuberculosis
- Participants with fungal infection
- Age < or = 18
- Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma
- Headache occurs < 4 hours per day
- Headache does not occur daily
- Headache is < 5 in severity on numerical analog scale
- Presence of increase in intracranial pressure or papilledema
- Active pregnancy
This trial is currently available in United States.
- Northwell Health North Shore University HospitalManhasset, United StatesContact: Jamie Ullman, MDTaking people
About the trial
What the trial wants to find out
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.
Treatments tested
- Methylprednisolone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of the Efficacy of Medrol Dose Pack for Post-Concussive Headaches
- Record updated
- 26 August 2026